About MOH Holdings
MOH Holdings: Enhancing Public Healthcare in Singapore
MOH Holdings is a leading holding company that oversees the management and development of Singapore's public healthcare institutions. The company was established in 2010 with the aim of enhancing public healthcare by unlocking synergies and economies of scale across the various healthcare institutions.
With a strong focus on innovation, MOH Holdings has been instrumental in driving significant improvements in Singapore's healthcare system. The company works closely with its subsidiaries to develop new technologies, processes, and systems that improve patient outcomes while reducing costs.
One of MOH Holdings' key strengths is its ability to bring together different stakeholders from across the healthcare industry. By fostering collaboration between hospitals, clinics, research institutes, and other organizations, MOH Holdings has created a vibrant ecosystem that supports innovation and growth.
The company's portfolio includes some of Singapore's most renowned healthcare institutions such as National University Health System (NUHS), SingHealth Group, Alexandra Health System (AHS), JurongHealth Services (JHS), National Healthcare Group (NHG) and St Luke’s Hospital.
NUHS is one of Asia's leading academic medical centers with a strong focus on research and education. SingHealth Group is another major player in Singapore's healthcare landscape with over 40 clinical specialties across its network of hospitals, national specialty centers, polyclinics and community hospitals. AHS operates Khoo Teck Puat Hospital which was designed to be environmentally friendly while providing high-quality care for patients. JHS operates Ng Teng Fong General Hospital & Jurong Community Hospital which are integrated facilities providing seamless care for patients from acute to post-acute settings under one roof. NHG provides primary care services through its network of polyclinics located island-wide while St Luke’s Hospital provides rehabilitation services for patients recovering from illnesses or injuries.
Together these institutions form an integrated network that delivers comprehensive care to patients throughout their journey – from prevention to diagnosis to treatment – all under one umbrella organization managed by MOH Holdings.
In addition to managing these institutions directly, MOH Holdings also invests heavily in research & development initiatives aimed at improving patient outcomes through innovative treatments & therapies as well as developing new technologies & devices that can help diagnose diseases earlier or more accurately than ever before.
One example is NUHS' Centre for Innovation in Healthcare which focuses on developing new solutions for chronic disease management using technology such as wearables or mobile apps combined with data analytics tools like machine learning algorithms or predictive modeling techniques so doctors can better monitor their patients remotely without having them come into hospital unnecessarily often saving time money resources etc..
Another example is SingHealth Duke-NUS Institute Of Precision Medicine which aims at advancing precision medicine through cutting-edge genomic sequencing technology combined with big data analytics capabilities enabling clinicians researchers scientists etc., access insights into how individual genetic variations may impact health outcomes allowing them tailor treatments accordingly thus improving overall quality life expectancy etc..
Overall MOH holdings plays an important role not only within Singapore but also globally given its reputation excellence innovation leadership expertise knowledge sharing best practices etc., making it an attractive partner collaborator investor destination many international players looking expand their presence Asia Pacific region beyond!
mohh.com.sg